The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
1 of 6 cited sources checked · 0 supported · 0 flagged · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesThe quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Normal and diabetic group sizes are reversed for the CIGMA comparison
MinorThe methods say the CIGMA comparison used 12 normal subjects and 11 diabetic patients, but the results report 11 normal subjects and 12 diabetic subjects.
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Flagged first, then by citations
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 27,601–27,700 of 31,469
Zhao, J.-Y., Shu, Y., Wang, S.-H., & Wu, H. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1834237 · Cited by 1
Mohamed, R. A. S. A. A., Hendawy, L. M. A., Farghaly, E., & Saleh, A. M. M. (2026) · Cardiovascular Diabetology – Endocrinology Reports · doi:10.1186/s40842-026-00293-5 · Cited by 2
Yang, K. L., Ma, Y., Ennis, G. E., Jonaitis, E., Reyes, R. E. R., Johnson, S. C., Ashton, N. J., Blennow, K., Zetterberg, H., & Bendlin, B. B. (2026) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.70383 · Cited by 2
Ma, H., Zhang, P., Fang, D., Bi, Y., & Gu, T. (2026) · BMC Endocrine Disorders · doi:10.1186/s12902-026-02344-5 · Cited by 1
Duenas‐Meza, E., Díaz-Granados, D. C. D. L. H., Giraldo‐Cadavid, L. F., Buendía-Deavila, M. E., Santos-Granados, A. M., Bazurto-Zapata, M. A., & Proaños-Jurado, N. J. (2026) · Sleep Medicine · doi:10.1016/j.sleep.2026.109078 · Cited by 1
Precision nutrition in MASLD should incorporate metabolic and inflammatory phenotyping
Ntikoudi, A. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1820240 · Cited by 1
Sepúlveda-Fragoso, V., Barreto-Reis, E., Carvalho, T. D. S., et al. (2026) · Food and Chemical Toxicology · doi:10.1016/j.fct.2026.116222 · Cited by 1
Effect of bariatric surgery on matrix metalloproteinase activity in patients with morbid obesity
Choromańska, B., Myśliwiec, P., Dadan, J., Tkaczuk, A., Wisniewski, K., Maleckas, A., Zalewska, A., Żendzian‐Piotrowska, M., & Maciejczyk, M. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1836747 · Cited by 1
Kim, K., Lee, C.-H., Kim, C.-E., Park, E.-Y., Hwang, J.-S., & Oh, Y. S. (2026) · Antioxidants · doi:10.3390/antiox15060755 · Cited by 1
Šiarnik, P., Rádiková, Ž., Kollár, B., Kutšálová, M., Penesová, A., Havranová, A., Imrich, R., Vlček, M., Žitňanová, I., Krastev, G., et al. (2026) · Neurology and Therapy · doi:10.1007/s40120-026-00982-4 · Cited by 2
Sarıkaya, E., Kilci, F., & Murat, N. Ö. (2026) · Acta Paediatrica · doi:10.1111/apa.70657 · Cited by 1
Yurtseven, K., Akbaba, A. K., Pınarlı, Ç., İbanoğlu, M. C., & Üstün, Y. E. (2026) · BMC Women s Health · doi:10.1186/s12905-026-04628-3 · Cited by 2
Serup, M. S., Palm, C. V. B., Dreyer, A. F., Grøntved, A., JØRGENSEN, J. S., Christesen, H. T., Jensen, T. K., Glintborg, D., & Andersen, M. S. (2026) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2026.103450 · Cited by 1
Bai, H., Xia, L., Song, L., et al. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1829984 · Cited by 1
Nobiletin ameliorates hepatic insulin resistance by modulating the gut–liver axis
Tang, E., Xiang, Q., Wang, N., Zhou, H., Chen, Z., He, Q., Yang, X., & Liao, W. (2026) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2026.110452 · Cited by 1
Gul, F., Ullah, A., Li, Y., Qian, Z., Cao, L., She, D., & Li, Y. (2026) · BMC Endocrine Disorders · doi:10.1186/s12902-026-02368-x · Cited by 1
Nandakumar, M., Moin, A. S. M., Sathyapalan, T., Butler, A. E., & Atkin, S. L. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27135841 · Cited by 1
Wan, D., Lee, J., Park, Y.-K., Xie, G., Maisto, S. K., Agyapong, C., Ozato, K., Gavrilova, O., & Ge, K. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2603875123
Özen, G. Ü., Büyükkasap, Ç., Dursun, B., & Akyol, A. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15135293 · Cited by 1
Beyond BMI: insulin resistance emerges as the key metabolic correlate of AMH in PCOS
Gorzko, A., Nawrocka-Rutkowska, J., Śliwak, E., et al. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1892970 · Cited by 1
Verde, L., Galasso, M., Colao, A., Barrea, L., & Muscogiuri, G. (2026) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2026.107038 · Cited by 2
Tığlı, A., Baykuş, Y., Deniz, R., Akıncı, G. E., Şener, N., Değirmenci, Y. E., Karakoç, O., Uzuner, M. B., Üstebay, S., Kilic, S., et al. (2026) · Metabolites · doi:10.3390/metabo16070488 · Cited by 1
Çaylak, E., & Maragheh, F. P. (2026) · Journal of Plant Biochemistry and Biotechnology · doi:10.1007/s13562-026-01085-9 · Cited by 2
Brennan, A. M., Green, J. F., Carnero, E. Á., Sparks, L. M., Goodpaster, B. H., Robinson, P. S., & Erickson, M. L. (2026) · The FASEB Journal · doi:10.1096/fj.202504084rr · Cited by 1
Jiang, J., Liang, Y., Wang, R., Jiang, W., Jing, X., & Yang, M. (2026) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.70343 · Cited by 1
U-shaped association between serum selenium levels and insulin resistance in Mexican schoolchildren
Hernández‐Mendoza, H., Ríos-Lugo, M. J., Klünder‐Klünder, M., Miranda‐Lora, A. L., Juárez-Flores, B. I., Moreno-Chavez, E., Martínez-Navarro, I., Arreguín, A., Álvarez-Loredo, H. E., & Vilchis‐Gil, J. (2026) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2026.127928 · Cited by 1
Naude, D., Smith, W. T., Mels, C. M. C., von Känel, R., & Wentzel, A. (2026) · Physiological Reports · doi:10.14814/phy2.71024 · Cited by 1
Vanlaer, Y., Embo, N., Bochanen, N., Wilder, N. V., Vereecke, G., Wierckx, K., Verhaegen, A., Coremans, P., Philips, J., Lytrivi, M., et al. (2026) · BMJ Open · doi:10.1136/bmjopen-2026-118191 · Cited by 1
Li, Y., Song, W., Huan, C., Xu, K., Sun, J., Zhen, X., Ouyang, H., Tang, H., Fan, Q., Zhi, W., et al. (2026) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2026.109089 · Cited by 3
Prevalence, Comorbidities, and Mortality of Obesity Classes 4 and 5 in Adults
Tran, K., Zhang, X., & Hartmann, P. (2026) · Obesity Science & Practice · doi:10.1002/osp4.70171 · Cited by 1
Doumatey, A. P., Idris, A., Zhou, J., et al. (2026) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2026.103456 · Cited by 1
Depot-specific differences in visceral and subcutaneous adipose tissue from patients with obesity
Neuhaus, M., Fryklund, C., Cai, M., Fernø, J., Mellgren, G., Hagberg, C. E., & Stenkula, K. G. (2026) · Adipocyte · doi:10.1080/21623945.2026.2708374 · Cited by 1
Khanal, M. K., Karimi, L., Saunders, P., Cavaggion, J., Nguyen, K., & de Courten, B. V. (2026) · Experimental Gerontology · doi:10.1016/j.exger.2026.113255 · Cited by 2
Mauras, N., Boettcher, C., Rasmussen, M. H., Soltysik, K., Jorge, A. A. L., Kashimada, K., Linglart, A., Luo, X., Murray, P. G., & Backeljauw, P. F. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag309 · Cited by 2
Badmus, O. O., Wahba, S., Arthur, G., Parrow, L. D., Montgomery, B., Cucolicchio, I. G., McGowan, K., & Taylor, E. B. (2026) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00871.2025 · Cited by 1
Gatti, A., Vandoni, M., Cavallo, C., Pellino, V. C., Rossi, V., Odone, A., Zuccotti, G., & Calcaterra, V. (2026) · European Journal of Pediatrics · doi:10.1007/s00431-026-07299-2 · Cited by 1
Lower glucagon response and attenuated hepatic glucagon signaling in MASLD
Kim, S. R., Hwang, Y., Lee, M., Choi, A., Lee, B., Kang, E. S., Cha, B., Kim, K. J., & Lee, Y. (2026) · Diabetes & Metabolism · doi:10.1016/j.diabet.2026.101787 · Cited by 1
Zhao, Y., Cao, Y., Mi, Y., et al. (2026) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.70496 · Cited by 1
Chen, C., Li, S., Liu, X., & Feng, X. (2026) · American Journal of Men s Health · doi:10.1177/15579883261479006 · Cited by 1
Glycemia, Insulin Sensitivity Markers and Arterial Stiffness: The Framingham Heart Study
Noumegni, S. R., Juraschek, S. P., Cohen, J. B., & Echouffo-Tcheugui, J. B. (2026) · Hypertension · doi:10.1161/hypertensionaha.125.26375 · Cited by 1
Petersen, M. C., Smith, G. I., Farabi, S. S., Palacios, H. H., Shankaran, M., Hellerstein, M. K., Patterson, B. W., & Klein, S. (2026) · Cell Metabolism · doi:10.1016/j.cmet.2026.07.020 · Cited by 5
Tirzepatide non-response with subsequent semaglutide response in class 2 obesity
Vignera, S. L., & Condorelli, R. A. (2026) · JCEM Case Reports · doi:10.1210/jcemcr/luag245 · Cited by 3
Gastaldelli, A., Choi, E., Conde‐Knape, K., Göransson, O., Krook, A., Lehtonen, S. H., Roden, M., Schrauwen, P., Sparks, L. M., & Heni, M. (2026) · Diabetologia · doi:10.1007/s00125-026-06853-9 · Cited by 1
Obesity, Insulin Resistance Pathway Factors, and Colon Cancer
Li, L. (2012) · Springer eBooks · doi:10.1007/978-1-4614-2367-6_7 · Cited by 1
Hernández, M. R. D. (2007) · Nefrología · Cited by 1
Pre-diabetes in Italian obese children and youngsters.
Brufani, C., Fintini, D., Ciampalini, P., Nocerino, V., Crea, F., Giannone, G., Patera, P. I., Valerio, G., Cappa, M., & Barbetti, F. (2011) · PubMed · doi:10.3275/7798 · Cited by 3
Trapp, S. K. (2015) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/7dxv-br44 · Cited by 1
Enos, R. T. (2013) · Scholar Commons (University of South Carolina) · Cited by 1
Using Gene Expression Signatures to Dissect Insulin Resistance Subtypes
Hayward, B., Konstantopoulos, N., & Ken, R. (2011) · InTech eBooks · doi:10.5772/22889 · Cited by 1
Odaguchi, H., Wakasugi, A., Oikawa, T., & Hanawa, T. (2012) · 和漢医薬学雑誌 · doi:10.11339/jtm.29.10 · Cited by 1
Effect of exogenous leptin on thrombotic and metabolic profiles of FVB/B6 lipodystrophic mice
Kadouh, H. C., Yang, S. J., IglayReger, H. B., & Bodary, P. F. (2013) · The FASEB Journal · doi:10.1096/fasebj.27.1_supplement.1183.4 · Cited by 1
Metabolic Aspects of Hepatitis C Virus Infection
Huang, J., Yu, M., Dai, C., Chuang, W., & Chang, W. (2012) · InTech eBooks · doi:10.5772/32494 · Cited by 1
Arase, Y., Heianza, Y., Hara, S., Ohmoto‐Sekine, Y., Amakawa, K., Tsuji, H., Ogawa, K., Saito, K., Kodama, S., Ikeda, K., et al. (2014) · Hepatology Research · doi:10.1111/hepr.12343 · Cited by 1
Alteraciones clínico-metabólicas en mujeres con diabetes gestacional previa
Rivas, A., González, J. C., de Guevara, M. C. L., & Dávila, S. G. (2010) · Revista de Obstetricia y Ginecología de Venezuela · Cited by 1
Uric acid levels in metabolically healthy and unhealthy obese patients
Akbaş, E. M. (2014) · Dicle Medical Journal / Dicle Tip Dergisi · doi:10.5798/diclemedj.0921.2014.04.0498 · Cited by 1
Insulinorresistencia y su asociación con aterosclerosis carotídea subclínica
Mesa, A. D. B., Rego, J. O. C., Sarmientos, J. C. G., et al. (2011) · Revista Cubana de Cardiología y Cirugía Cardiovascular · Cited by 1
Kim, M., & Tanaka, K. (2014) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2014.0032 · Cited by 1
Yajima, K., Shimada, A., Hirose, H., Oikawa, Y., Yamada, S., Meguro, S., Irie, J., & Irie, S. (2009) · Clinical Drug Investigation · doi:10.2165/11530610-000000000-00000 · Cited by 1
Aumento do Risco Cardiovascular em Mulheres com Síndrome Metabólica
Teixeira, R. J., Leite, A. B., Farias, C. A. S. A., Sousa, C. R., Yugue, A. M., Aguiar, A. A., Ginzbarg, D., & Padula, M. I. (2008) · Revista Brasileira de Medicina de Família e Comunidade · doi:10.5712/rbmfc3(12)359 · Cited by 1
Zhou, A. L. (2021) · Digital Commons - USU (Utah State University) · doi:10.26076/a9ed-ea57 · Cited by 1
An Analysis on Risk Factors of Colon Polyps with Health Examination Examinees
Park, Y.-H., Yu, J.-H., & Lee, T. (2014) · Journal of the Korea Academia-Industrial cooperation Society · doi:10.5762/kais.2014.15.3.1641 · Cited by 1
Insulinorresistencia, obesidad y síndrome metabólico. Cohorte CDC de Canarias en Venezuela
Viso, M., Rodríguez, Z., Aponte, L., Carmiol, A. M., Barreto, P., de León, A. C., Fernández, Y., Galdona, E., Reigosa, A., & Callegari, C. C. (2013) · Redalyc (Universidad Autónoma del Estado de México) · Cited by 1
López, G., Gutiérrez, S., Chiquete, E., et al. (2011) · Revista de Endocrinología y Nutrición · Cited by 1
Santhanam, P., Elkadry, A., Khthir, R. A., et al. (2015) · Journal of Clinical Hypertension · doi:10.1111/jch.12600 · Cited by 1
Pentraxin 3 Levels as a Marker of Chronic Inflammation in Patients With Metabolic Syndrome
Kızılgül, M., Uzunlulu, M., Karacakaya, M., et al. (2013) · Journal of Endocrinology and Metabolism · doi:10.4021/jem.v2i6.142 · Cited by 1
Olmesartan for non-alcoholic steatohepatitis complicated with hypertension: An open-label study
Hidaka, H., Ohbu, M., Matsumoto, Y., Minamino, T., Takada, J., Tanaka, Y., Okuwaki, Y., Watanabe, M., Nakazawa, T., Shibuya, A., et al. (2013) · Open Journal of Gastroenterology · doi:10.4236/ojgas.2013.32021 · Cited by 1
Haufe, S., Engeli, S., & Jordan, J. (2012) · Circulation Heart Failure · doi:10.1161/circheartfailure.112.970749 · Cited by 1
Castro-Dufourny, I., de la Morena, L. H., Borge, V. M., & Sánchez, L. F. P. (2009) · Revista Clínica Española · doi:10.1016/s0014-2565(09)70627-7 · Cited by 1
Ohta, Y., Kawano, Y., Iwashima, Y., Hayashi, S., Yoshihara, F., & Nakamura, S. (2012) · Journal of Human Hypertension · doi:10.1038/jhh.2012.64 · Cited by 1
Eingeschränkte Fitness vs. Adipositas
Esefeld, K., Halle, M., & Blair, S. N. (2011) · Der Diabetologe · doi:10.1007/s11428-010-0614-7 · Cited by 1
Walton, T. A., Nishtar, S., Lumb, P. J., Crook, M. A., Marber, M. S., Gill, J. S., & Wierzbicki, A. S. (2014) · International Journal of Clinical Practice · doi:10.1111/ijcp.12520 · Cited by 1
The effects of metformin plus sulfonylurea therapy on clinical features of the metabolic syndrome
Koprivica, B., Živković, T. B., & Ille, T. (2010) · Medicinski pregled · doi:10.2298/mpns1010611k · Cited by 1
TNF Antagonists, The Prevention of Myocardial Infarction in Rheumatoid Arthritis Patients?
Yeo, L. T. (2013) · Res Medica · doi:10.2218/resmedica.v21i1.185 · Cited by 1
Żebrowska, A. (2010) · Biophilia Rehabilitation Journal · doi:10.3774/brj.6.27 · Cited by 1
Madziarska, K., Zmonarski, S. C., Penar, J., Krajewska, M., Mazanowska, O., Augustyniak‐Bartosik, H., Gołębiowski, T., Kłak, R., Weyde, W., & Klinger, M. (2014) · International Urology and Nephrology · doi:10.1007/s11255-014-0900-1 · Cited by 1
Resultados del bypass gástrico resectivo en pacientes obesos mórbidos ≤ 18 años y ≥ 65 años
Ana María Burgos, L., Attila Csendes, J., & Papapietro, K. (2008) · Revista médica de Chile · doi:10.4067/s0034-98872008001000003 · Cited by 1
Visfatin Polymorphism May Increase Tendency to Diabetic Nephropathy
Demir, S., Özgöz, A., İçduygu, F. M., et al. (2012) · Nephrology Research & Reviews · doi:10.4081/nr.2012.e4 · Cited by 1
Moon, K., Park, I. K., Jo, Y. S., et al. (2011) · Journal of Nutrition and Health · doi:10.4163/kjn.2011.44.4.292 · Cited by 1
The prognosis of patients with coronary artery disease complicated by postload hyperinsulinemia
Yamasa, T., Ikeda, S., Koga, S., Nakatomi, D., Mutoh, S., Sonoda, K., Hata, S., & Maemura, K. (2014) · IJC Metabolic & Endocrine · doi:10.1016/j.ijcme.2014.07.008 · Cited by 1
Insuficiencia renal y resistencia insulínica: efecto de la dosis de diálisis
Mínguez, C., López-Suárez, A., Soto, M. J., et al. (2007) · Revista Clínica Española · doi:10.1157/13109833 · Cited by 1
Kakita, A., Suzuki, A., Nagata, M., & Itoh, M. (2008) · Anti-aging Medicine · doi:10.3793/jaam.5.82 · Cited by 1
Hassan, M. F. (2014) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.5455/2320-1770.ijrcog20140303 · Cited by 1
Performance of four risk scores for predicting insulin resistance in Thai adults
Srisung, W., Saprungruang, A., & Jiamjarasrangsi, W. (2012) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-012-0066-2 · Cited by 1
Zhang, X., Chen, T., Long, Y., Ran, X., & Tian, H. (2013) · Journal of Diabetes · doi:10.1111/1753-0407.12075 · Cited by 1
YAGURA, C., Kihara, I., Hashimot, M., Iwamoto, M., Yamasaki, M., Hanaoka, H., Nogi, A., & Shiwaku, K. (2009) · Journal of Physical Therapy Science · doi:10.1589/jpts.21.337 · Cited by 1
Bahijri, S., Qusti, S. Y., Khormi, F., Alshali, K. Z., Jambi, H., & Hashem, E. (2015) · Journal of Advances in Medicine and Medical Research · doi:10.9734/bjmmr/2015/14374 · Cited by 1
Effect of Nephropathy on the Composition of Apolipoprotein-Containing Particles in NIDDM
Nagai, T., Tomizawa, T., Nakajima, K., et al. (1998) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat1994.5.54 · Cited by 1
Lazaro, K., Luz, V. A., & Sapang, B. (2012) · Journal of the ASEAN Federation of Endocrine Societies · doi:10.15605/jafes.027.02.11 · Cited by 1
Díez, J. J., Grande, C., Méndez, J., et al. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02541.x · Cited by 1
Sedehi, M., Mehrabi, Y., Kazemnejad, A., et al. (2010) · Neural Computing and Applications · doi:10.1007/s00521-010-0436-y · Cited by 1
RetractedVázquez, C., Arrieta, F., Piñera, M., Balsa, J. A., Martı́nez-Botas, J., Gómez‐Coronado, D., Calañas, A., Zamarrón, I., & Botella-Carretero, J. I. (2014) · e-SPEN Journal · doi:10.1016/j.clnme.2014.06.004 · Cited by 1
The clinical relevance of fasting serum insulin levels in obese subjects
Crowther, N. J. (2004) · Journal of Endocrinology Metabolism and Diabetes of South Africa · doi:10.1080/16089677.2004.11073591 · Cited by 1
Estimer la sensibilité à l’insuline : trop d’outils tuent-ils l’outil ?
Disse, E., Elisha, B., Fellahi, S., RABASA-LHORET, R. P. R., Laville, M., & Bastard, J. (2013) · Obésité · doi:10.1007/s11690-013-0367-8 · Cited by 1
Tanyanskiy, D. A., & Denisenko, A. D. (2011) · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry · doi:10.1134/s1990750811030140 · Cited by 1
Çalışkan, M., Pamuk, B. Ö., Güllü, H., Çiftçi, Ö., Çalışkan, Z., Erdoğan, D., Güven, A., Polat, E., & Müderrisoğlu, H. (2012) · The Anatolian Journal of Cardiology · doi:10.5152/akd.2013.006 · Cited by 1
Behary, P., Godsland, I. F., & Baynes, K. (2014) · Practical Diabetes · doi:10.1002/pdi.1867 · Cited by 1
Insulin Resistance and Hypogonadism
Amin, M. R., Pathan, M. F., Aktaruzzaman, A., Qureshi, N. K., Akter, F., Rahman, S., Huq, M. E., Shermin, S., & Rahman, M. R. (2013) · Delta Medical College Journal · doi:10.3329/dmcj.v1i1.14968 · Cited by 1
Two-Stage Evaluation for Selecting Individuals for Chronic Disease Lifestyle Guidance
Hori, S., Takahashi, T., & Kitagawa, Y. (2008) · Health Evaluation and Promotion · doi:10.7143/jhep.35.416 · Cited by 1
Effects of Metformin on Thyroid Function in Patients of Subclinical Hypothyroidism
Rajput, R., Saini, M., Rajput, M., & Shankar, V. (2013) · Journal of Endocrinology and Metabolism · doi:10.4021/jem.v3i4-5.188 · Cited by 1
Stern, J. S. (2011) · Obesity · doi:10.1038/oby.2010.334 · Cited by 1
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
